These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 11356083)

  • 1. Generation of recombinant adeno-associated virus vectors by a complete adenovirus-mediated approach.
    Zhang X; Li CY
    Mol Ther; 2001 May; 3(5 Pt 1):787-92. PubMed ID: 11356083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
    Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
    Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.
    Liu XL; Clark KR; Johnson PR
    Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
    Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
    Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.
    Chadeuf G; Favre D; Tessier J; Provost N; Nony P; Kleinschmidt J; Moullier P; Salvetti A
    J Gene Med; 2000; 2(4):260-8. PubMed ID: 10953917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
    Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
    Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant adenovirus expressing adeno-associated virus cap and rep proteins supports production of high-titer recombinant adeno-associated virus.
    Zhang HG; Wang YM; Xie JF; Liang X; Hsu HC; Zhang X; Douglas J; Curiel DT; Mountz JD
    Gene Ther; 2001 May; 8(9):704-12. PubMed ID: 11406765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of an antisense-mediated prepackaging cell line for adeno-associated virus vector production.
    Okada T; Mizukami H; Urabe M; Nomoto T; Matsushita T; Hanazono Y; Kume A; Tobita K; Ozawa K
    Biochem Biophys Res Commun; 2001 Oct; 288(1):62-8. PubMed ID: 11594752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy.
    Małecki M; Swoboda P; Pachecka J
    Acta Pol Pharm; 2009; 66(1):93-9. PubMed ID: 19226976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector.
    Vermeij J; Zeinoun Z; Neyns B; Teugels E; Bourgain C; De Grève J
    Br J Cancer; 2001 Nov; 85(10):1592-9. PubMed ID: 11720450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations.
    Shen WY; Lai CM; Lai YK; Zhang D; Zaknich T; Sutanto EN; Constable IJ; Rakoczy PE
    J Gene Med; 2003 Jul; 5(7):576-87. PubMed ID: 12825197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-amplification system for recombinant adeno-associated virus production.
    Urabe M; Shimazaki K; Saga Y; Okada T; Kume A; Tobita K; Ozawa K
    Biochem Biophys Res Commun; 2000 Sep; 276(2):559-63. PubMed ID: 11027513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction, packaging and titration of recombinant adeno-associated virus vectors contaning antitumor genes].
    Zhang Y; Leng X; Peng J; He X; Lu J; Weng S; Wang S; Du J
    Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):564-7. PubMed ID: 12133507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [hEPO transfer and expression by a recombinant adeno-associated virus vector].
    Wu ZJ; Wu XB; Wang H; Lu B; Dong XY; Hou YD
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Mar; 34(2):176-80. PubMed ID: 12006992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6.
    Allen JM; Halbert CL; Miller AD
    Mol Ther; 2000 Jan; 1(1):88-95. PubMed ID: 10933916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular contaminants of adeno-associated virus vector stocks can enhance transduction.
    Tenenbaum L; Hamdane M; Pouzet M; Avalosse B; Stathopoulos A; Jurysta F; Rosenbaum C; Hanemann CO; Levivier M; Velu T
    Gene Ther; 1999 Jun; 6(6):1045-53. PubMed ID: 10455407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased titer of recombinant AAV vectors by gene transfer with adenovirus coupled to DNA-polylysine complexes.
    Mamounas M; Leavitt M; Yu M; Wong-Staal F
    Gene Ther; 1995 Aug; 2(6):429-32. PubMed ID: 7584119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of packaging cell lines for generation of adeno-associated virus vectors by lentiviral gene transfer of trans-complementary components.
    Nakamura S; Nakamura R; Shibata K; Kobayashi M; Sahara N; Shigeno K; Shinjo K; Naito K; Ohnishi K; Kasahara N; Iwaki Y
    Eur J Haematol; 2004 Oct; 73(4):285-94. PubMed ID: 15347316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells.
    Durocher Y; Pham PL; St-Laurent G; Jacob D; Cass B; Chahal P; Lau CJ; Nalbantoglu J; Kamen A
    J Virol Methods; 2007 Sep; 144(1-2):32-40. PubMed ID: 17467815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery.
    Chadeuf G; Ciron C; Moullier P; Salvetti A
    Mol Ther; 2005 Oct; 12(4):744-53. PubMed ID: 16023415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.